Cargando…
Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis
The introduction of imatinib has substantially changed the approaches to the therapy of chronic myeloid leukemia. However, this drug can cause hepatic failure and death in rare cases. This report describes a clinical case of acute, toxic imatinib-induced hepatitis in a 56-year-old woman with chronic...
Autores principales: | Lopina, Nataliia, Dyagil, Iryna, Hamov, Dmytro, Zhuravlyova, Larysa, Dmytrenko, Iryna, Lopin, Dmytro, Igor, Kuznetsov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188217/ https://www.ncbi.nlm.nih.gov/pubmed/30345193 http://dx.doi.org/10.7759/cureus.3136 |
Ejemplares similares
-
Novel Score-based Decision Approach in Chronic Myeloid Leukemia Patients After Acute Toxic Imatinib-induced Liver Injury
por: Lopina, Nataliia, et al.
Publicado: (2019) -
A New Paradigm of Cardio-Hematological Monitoring in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
por: Lopina, Nataliia, et al.
Publicado: (2022) -
Development and Validation of a Sulfa Antibiotic Allergy Clinical Decision Rule
por: Waldron, Jamie L., et al.
Publicado: (2023) -
“Doctor, I have a Sulfa Allergy”: Clarifying the Myths of Cross-Reactivity
por: Shah, Tirth J., et al.
Publicado: (2018) -
Bullous Lupus: An Atypical Case of Refractory Disease in a Patient with Sulfa Allergy
por: Salgado Guerrero, Maria, et al.
Publicado: (2020)